Comparison window: 15 Jun 2022 → 8 Sept 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared
Report produced on 10 September 2026 · data as of the dates shown per section Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat Public methodology: rebalix.com/en/methodology
Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.
From 15 Jun 2022 to 8 Sept 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
In today’s purchasing power (net of Italy inflation)
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.
How far they fell — drawdown from peak (nominal)
In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
Filled area: XQUD; thin lines: the other funds.
The worst episode, fund by fund
Fund
Max drawdown
Trough
Recovery time
Underwater
XQUD
−11.7%
20 Oct 2023
388 days
809 days · back to break-even on 11 Nov 2024
XQUA
−19.5%
22 Apr 2025
not yet
1,496 days (ongoing)
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.
Drawdown net of Italy inflation
Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
63 common holdings · ticker match on full official portfolios
How the shared part is computed: for each security held by both funds, only the SMALLER of the two weights counts — a stock at 5% in one fund and 1% in the other overlaps by 1%, not 5%. Summed over all 63 common holdings this gives 100.0%: buying both funds, roughly this share of your money buys the same stocks twice. Matching is by company (one issuer does not publish security identifiers): identical holdings written differently may be missed, so the real overlap can be higher than shown.
XQUD: issuer page 20 Aug 2026 · XQUA: issuer page 20 Aug 2026
Duration band
medium (3–7 years)
medium (3–7 years)
short ≤3 · medium 3–7 · long >7 yrs
Investment-grade share
not declared
not declared
BBB−/Baa3 and above
Heaviest rating bucket
not declared
not declared
—
Most represented maturity
7–10 years (20.3%)
7–10 years (20.3%)
—
Distributions (fund currency)
Frequency
accumulating class
semi-annual
—
Distributions, last 12 months
accumulating class
0.4933 USD
per share
Distribution yield
accumulating class
4.82%
12 months / NAV
Last ex-date
accumulating class
19 Aug 2026 · 0.2457 USD
—
Italian taxation
Effective capital-gains rate
15.75%
15.75%
white list, current half-year
Documents & exchanges
Listing venues
8
9
ESMA register
Borsa Italiana ticker
—
XQUA
—
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~303 euro XQUD · ~303 euro XQUA. Broker costs not included.
Disclaimer
This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.
Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.
Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.
Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.